BOSTON SCIENTIFIC CORP

BSX

Form 4 • Statement of Changes in Beneficial Ownership

SEC Accession Number: 0001225208-26-003180
Filing date: Mar 4, 2026
Earliest execution date: Mar 2, 2026
Reporting Owners: Pegus Cheryl (Director)

Summary

Type

Neutral

Net shares

0

% of shares

0.00%

Amount (USD)

$0

Insider confidence score

52.5 out of 100

Positive

  • Minimal sell amount (<$10K)

Derivative Transactions

Transaction 1

Security

Deferred Stock Units

Action

Grant

Date

2026-03-02

Code

A

Net shares

+24.0

Acquired/Disposed

Acquired

Shares Owned Before

5,893.0

Shares Owned After

5,917.0

Filing's footnotes

1. Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.

2. Deferred stock units granted in lieu of 50% yearly cash compensation, vesting in full upon the next annual meeting of stockholders. Vested shares of stock will be issued to the reporting person following the reporting person's separation from Board of Directors service in accordance with the Company's Non-Employee Director Deferred Compensation Plan. Reflects a value of $1,845.25, divided by the closing price of the common stock on the date of grant.

This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.